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IN PERSPECTIVE
Impact of Dietary Components on NK and Treg Cell
Function for Cancer Prevention
Young S. Kim,1* Thomas J. Sayers,2 Nancy H. Colburn,2 John A. Milner,3 and Howard A. Young2
1

Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland
Frederick National Laboratory, Center for Cancer Research, NCI, Frederick, Maryland
3
Human Nutrition Research Center, USDA/ARS, Beltsville, Maryland
2

An important characteristic of cancer is that the disease can overcome the surveillance of the immune system. A possible
explanation for this resistance arises from the ability of tumor cells to block the tumoricidal activity of host immune cells
such as natural killer (NK) cells by inducing the localized accumulation of regulatory T (Treg) cells. Evidence exists that
components in commonly consumed foods including vitamins A, D, and E, water-soluble constituents of mushrooms,
polyphenolics in fruits and vegetables, and n-3 fatty acids in ﬁsh oil can modulate NK cell activities, Treg cell properties, and
the interactions between those two cell types. Thus, it is extremely important for cancer prevention to understand the
involvement of dietary components with the early stage dynamics of interactions among these immune cells. This review
addresses the potential signiﬁcance of diet in supporting the function of NK cells, Treg cells, and the balance between
those two cell types, which ultimately results in decreased cancer risk. Published 2015. This article is a U.S. Government work and is in the
public domain in the USA.
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INTRODUCTION
Natural Killer (NK) cells are large granular lymphocytes without B or T cell characteristics and highly
effective in destroying tumor cells and virally infected
cells without the need for prior sensitization or
recognition of a specific antigen [1–3]. These cells
represent innate immune cells that secrete cytokines
participating in the adaptive immune response. For
example, NK cells are a major source of protective
cytokine IFN-g that is critical for the development of
an appropriate cytotoxic T cell response to the
pathogen. The direct and indirect tumoridical properties of NK cells equip them with the ability to serve
as a critical sentinel against invading pathogens. Both
experimental and clinical data indicate an important
role for NK cells in early neoplastic development,
possibly by either responding to pathogen-associated
molecular patterns (PAMPs) or to various types of
extracellular or cell-associated proteinases [4,5]. Cancer cells often evade NK-cell surveillance by producing immunosuppressive molecules and through the
recruitment of tolerance-related Treg cells [6,7].
Treg cells (CD4 þ , CD25 þ , fork head box p3
[Foxp3] þ) that characteristically express the nuclear
transcription factorFoxp3, are known to down-regulate the tumoricidal activity of NK cells and thus
maintain immunological self-tolerance and homeostasis. No doubt, it is important to understand the
early stage(s) of pathogen-host interactions, and
redirect these events from a pro-tumor to an antitumor state. Diet may represent a subtle approach to
regulating NK cells without losing their homeostasis

maintained by regulatory T cells. Here, we will discuss
our current understanding of the mechanism by
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Several lines of evidence suggest that a number of
bioactive food components can induce tumor cell
death, possibly by enhancing NK cell activity. For
example, water-soluble extracts of the dried Brazilian
sun- (Agaricus Blazei) and Maitake- (Grifola frondosa)
mushrooms can enhance the cytolytic activity of NK
cells in BALB/c mice [8–10]. Likewise, dietary supplementation with vitamin E (250 mg daily for 2 wk) can
enhance NK cell cytolytic activity in advanced
colorectal cancer cells obtained from patients [11].
Interestingly, the supplementation of vitamin E
(administered at 100 mg/day for 8 wk) restored NK
cell activity in a 16-month-old boy with Shwachman–
Diamond syndrome which is classically associated
with a persistent reduction in NK cytolytic activity
[12]. Collectively, these findings suggest the involvement of dietary components in the regulation of NK
cell tumoricidal activity. In this review, we propose
three distinct processes: receptor-ligand interactions,
the release of cytokines, and the secretion of lytic
enzymes (Figure 1) as possible mechanisms explaining their actions.

complex (MHC) class I molecules, which in humans
are human leukocyte antigen (HLA) class I molecules [16]. The inhibitory KIRs block NK cytotoxicity
for cells that express normal levels of MHC class I
molecules on their surface [17].
There is evidence, admittedly limited, that suggests
certain dietary components may modulate the NK cell
activity in response to tumor antigen stimuli. For
example, when STAV-AB malignant mesothelioma
cells are exposed to 7.5 mM selenite for 24 h, these cells
become highly sensitive to NK cells [18]. This event is
possibly caused by the observed selenite-mediated
loss of tumor antigen HLA-E on the surface of STAVAB cells as this molecule can bind to the CD94/
NKG2A receptor on NK cells and thereby suppress
their tumoricidal activities.
The tumor antigen, HLA-G has tolerogenic properties and provides tumor cells with an efficient way to
escape from NK tumoricidal function. This effect of
HLA-G appears to be independent of lipid raft
integrity that could be modulated by a variety of
lipid soluble dietary factors including n-3 polyunsaturated fatty acids (PUFAs) abundant in fish oil and
conjugated linoleic acids (CLAs) found in dairy
products [19–22]. For example, n-3 PUFAs and cis-9,
trans-11-CLAs target lipid raft organization in membrane to influence immune cell function [21,22].
However, HLA-G is mainly localized outside the lipid
rafts of tumor cells during this process and so remains
unaffected by these dietary components.

Interaction of Bioactive Food Components With NK Cell
Receptors and Their Ligands

Influence of Bioactive Food Components on Cytokine
Release From NK Cells

NK cells are known to exhibit their activity through
a diverse repertoire of activating (e.g., NKG2 receptor
family) and inhibitory (e.g., killer immunoglobulinlike receptor [KIR] family) receptors that recognize
specific ligands on the surface of target cells [13–15].
Many of the KIRs recognize major histocompatibility

Circulating NK cells, as opposed to dendritic cells,
only mature during inflammation or infection [23–
25]. NK cells, which can lyse tumor cells, provide
antigenic cellular debris for mature dendritic cells to
present to T cells; in later stages of an immune
response, NK cells terminate the process by lysing the

which dietary components modulate the function
and balance between NK cells and Treg cells for cancer
prevention. Papers that do not provide evidence
dealing with the effects of specific dietary constituents on the targeted immune-prevention are not
included for the discussion.
DIETARY INFLUENCE ON NK CELL PROPERTIES

Figure 1. Dietary components modulate tumoricidal activity of NK cells by three distinct processes including receptorligand interactions, the release of cytokines, and the secretion of lytic enzymes. Speciﬁc examples are discussed in the
text under section “DIETARY INFLUENCE ON NK CELL PROPERTIES.” This ﬁgure does not reﬂect the actual size of cells.
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dendritic cells and halting their ability for antigen
presentation [26,27]. During early onset of inflammation, immature dendritic cells secrete a variety of
cytokines including tumor necrosis factor-a (TNF-a),
IL-2, IL-12, and IL-18 [24,25]. These cytokines can
induce a rapid expression of IFN-g and subsequently
enhance the intrinsic cytolytic activity of NK
cells [27]. However the response is complex, since Thelper 2 (Th2) cytokines such as IL-4, which are
generally viewed as an antagonist of IFN-g expression
in T cells, can induce signal transducer and activator
of transcription 6 (STAT6)-dependent IFN-g secretion
by NK cells [28].
Dietary supplementation of 4-month-old C57BL/6
mice with 10% (Wt/Wt) white button mushroom
powders for 10 wk increased the production of TNF-a,
IL-2, and IFN-g, which correlated with the increased
tumoricidal activity of splenic NK cells [29]. Unfortunately, this study does not allow for the determination if the increased production of cytokines is
mediated via dendritic cells or from the direct effect
of mushroom powders on NK cell function.
Recently, LPS stimulated dendritic cells were found
to increase the release of IFN-g following isoflavone
(100 mM genistein or daidzein), which in turn
enhanced the cytolytic effects of NK cells in culture [30]. While it appears that soy isoflavones
stimulate the release of cytokines from matured
dendritic cells, it remains unclear how these cytokines
activate the NK cell function.
It is reported that supplementation of mice with
galacto-oligosaccharides (5 g/kg b.w. for 2 wk), a
soluble fiber found in human milk, increases the NK
cell-mediated protection against Helicobacter infection in a Smad3-deficient inflammation model [31].
This effect of a milk component on NK cell activity is
possibly associated with the increased expression of
the NK chemokine receptor CCR 9 as the binding by
its ligand CCL25 is known to decrease the severity of
pathogen-induced inflammation in the colon. While
these results suggest that specific bioactive food
components can modulate the ability of NK cells to
respond to various cytokines, the precise mechanism(s)
remains unresolved.
Dietary Modulation of Release of Lytic Granules From
NK Cells
The lysosomal release of cytotoxic granules from
NK cells, including two membrane-perturbing proteins such as perforin and granulysin, and a family of
serine proteases (also known as granzymes), constitutes the main pathway for the NK-mediated elimination of tumor cells [27,32–34]. A number of studies
indicate that dietary habits, including alcohol consumption and caloric restriction, may influence the
cytolytic activity of NK cells by down-regulating the
release, activity, and expression of perforin and
granular proteases [35–38]. Restricting calorie intake
(starting with 10% restriction at the age of 10 wk and
Molecular Carcinogenesis
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gradually increased up to 40% at the age of 14 wk and
after) in mice was reported to reduce NK cell number
and function particularly cytolytic activity as evident
by their decreased ability to resist against influenza
virus infection [37]. While the mechanism for these
changes in NK cells remains unclear, the significance
of the PI3K signaling cascade in NK cell biology [39]
and the recent finding that inositol (1,3,4,5) tetrakisphosphate (IP4) suppresses NK cell granule exocytosis and target-cell killing [40], may explain a possible
mechanism. IP4 is a soluble metabolite generated
from the membrane lipid phosphatidylinositol-4, 5diphosphate (PI [4,5] P2). This compound is reported
to be critical in immune cell development and
function in hematopoietic cells [41]. Knocking-out
of ItpkB, an enzyme that is essential for the production of IP4, revealed that this phosphorylated inositol
metabolite promotes NK cell maturation and limits
NK cell responsiveness [40]. It is known that caloric
restriction reduces tumor incidence and numbers in
animal models. Further studies are warranted to
examine how NK cells play a role in these dynamics
involving the tumor micro-environment, energy
homeostasis, and host immunity.
DIETARY COMPONENTS MODULATE Treg CELL
INDUCTION
Treg cells represent 5–10% of total CD4þ T
lymphocytes in humans and mice, these cells constitute about one fifth of tumor T-cell infiltrates [2,42,43]
suggesting their active role in the tumor microenvironment. Under normal conditions, Treg cells are
known to have a role in developing tolerance to
nonpathogenic foreign antigens, (e.g., foods or
commensal bacteria) to avoid inappropriate immune
responses. Within a tumor site, these regulatory
T cells can suppress cancer cell-specific immune
reactions, resulting in the cytokine profile that is
typically immunosuppressive. For example, transforming growth factor-b (TGF-b), a tumor cell secreted cytokine that can convert antigen-activated
peripheral CD4þ T cells to CD4 þ CD25þ Treg cells,
suppresses tumoricidal activity of CD8 (þ) cytotoxic T
lymphocyte (CTL) and NK cells [44]. Through this
mechanism, tumor cells escape from either CTL or NK
cell-attacks by utilizing Treg cells that are recruited to
the tumor by the chemokine ligand CCL22 that is
produced by tumor cells and/or tumor-associated
macrophages [45].
There are two different types of Treg cells, naturally
occurring Treg (nTreg) and inducible Treg (iTreg) [46].
The former suppresses T-cell responses by cell contactdependent mechanisms, whereas the latter secretes
inhibitory cytokines, including TGF-b and interleukin-10 (IL-10). While both nTreg cells and iTreg cells
are known to modulate NK cell cytotoxicity in vitro
and in vivo [47,48], the precise mechanism explaining how this works largely remains unclear.
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A few bioactive food components including vitamin A [49,50], vitamin D [51–53], n-3 fatty acids
[54,55], dietary polyphenolics such as naringenin
[56], and epigallocatechin-3-gallate (EGCG, 57) are
shown to induce peripheral iTreg cells to escape from
immune effector cells including NK cells and thereby
prevent autoimmunity and allergy. The effects of
iTreg cells are carried out by modulating several
processes including the inhibition of dendritic cell
(DC) differentiation/maturation [48], stimulation of
TGF-b release from the membrane of Treg cells [58],
and the modulation of NK-cell perforin and granzyme
B expression [59]. However, it remains to be revealed
which pathway(s) is modulated by these dietary
constituents to exert their preventive effects on
autoimmunity and allergy. With that limit, this
section will focus on the currently known role of
dietary constituents in the properties of iTreg cells at
peripheral tissues.
Vitamin A Modulates the Induction of Regulatory T Cells
in Intestine, Which Promotes NK Tolerance Against Foods
and Commensal Gut Bacteria
Antigen presenting cells (APCs) such as DCs harbor
retinaldehyde dehydrogenase that metabolizes vitamin A to retinoic acid (RA) [60,61]. RA is reported to
be critical for TGF-b-dependent iTreg generation in
the intestine where immune tolerance towards foods
and commensal microbes is important to maintain
homeostasis (62, Figure 2). The conversion to iTreg
(CD4 þ Foxp3þ Treg) cells from naı̈ve T (CD4 þ
Foxp3-) cells may be mediated by a specific population of dendritic cells that are identified by a CD103
marker in the lamina propria of the small intestine [49,63]. It is notable that a conserved non-coding
sequence 1 (CNS1) in the Foxp3 locus, which contains
TGF-b-Smad/NFAT response elements, has a critical
role in iTreg cell generation in gut-associated lym-

phoid tissues [64,65]. In addition, the inhibitory
effects of retinoic acids on the release of proinflammatory cytokines such as IL-4, IL-21, and
IFN-g from CD44(hi)CD4(þ) memory T cells appears
to contribute to the process (50, Figure 2). Interestingly, this cytokine-mediated indirect effect of RA is
shown to require the expression of its nuclear receptor
retinoic acid receptor-a (RAR-a) [66]. The binding of
RA to RAR-a can block cytokine production by
effector T cells, which in turn facilitates Treg induction and down-regulates NK function. Finally, RA is
reported to actively participate in the TGF-b-dependent reciprocal regulation of iTreg (anti-inflammatory) versus Th17 (pro-inflammatory) cells by inhibiting
the IL6-driven induction of the latter (67, Figure 2).
The priming of naı̈ve T cells by DC in the presence of
TGF-b leads to either anti-inflammatory Treg cells or
pro-inflammatory Th17 cells [67]. Vitamin A metabolite RA was demonstrated as a key determinant driving
this pathway toward anti-inflammatory Treg cell
induction mediated by mucosal DC. This property
of RA seems to be particularly important in the
intestine, where efficient immune protection is
required to maintain homeostasis in response to
constant exposure to exogenous stimuli. Overall, the
experimental results suggest that vitamin A may be
involved with the fine-tuning of T cell differentiation
into Treg in the intestine, which generates NK
tolerance against external and internal antigens.
Vitamin D Inhibits Dendritic Cell Maturation and Thereby
Increases the Induction of Treg Cells
Studies have consistently shown that exposure of
DCs to 1,25(OH)2D3, the active form of vitamin D,
leads to the inhibition of differentiation and maturation of these cells [68–70]. In vitro treatment of DCs
with 1,25(OH)2D3 has been shown to decrease IL-12
and enhance IL-10 production, resulting in decreased

Figure 2. A naïve T cell can be differentiated into any Th effector cells depending on the cytokines released into
the microenvironment. Dietary constituents including vitamin A metabolite retinoic acids, vitamin D, and
polyphenolics are shown to inhibit the expression of various cytokines such as IL4, IL6, and IL12, and thereby
increase TGFb-dependent peripheral Treg induction.
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T-cell activation (68, Figure 2). This effect of vitamin D
seems to be mediated by vitamin D receptor (VDR) as
shown in the study utilizing VDR knockouts [69]. The
modulating activities of 1,25(OH)2D3 on DCs and T
cells were abolished in these mice with limited
expression of VDR. Furthermore, 1,25(OH)2D3 selectively works on myeloid DCs but not plasmacytoid
DCs, suggesting that the differentially produced
cytokines in former cells such as IL-12 may play a
significant role throughout the process [70,71]. Therefore, the VDR mediated inhibition of myeloid DC
maturation, coupled with changes in cytokines such
as IL-10 and IL-12 appears to ultimately render the
myeloid DCs to be either inactive or tolerogenic
[68,70].
The changes in anti- and pro-inflammatory cytokines in the 1,25(OH)2D3 or VDR deficient mice has a
key role in favoring Treg induction in peripheral
tissues [72]. For example, DCs secreting IL-10 induce
iTreg cells that do not express Foxp3 (Fox3-) [51].
These Foxp3 IL-10þ Treg cells possess immune
suppressive properties and commonly named Tr1 (T
regulatory type-1) or Tr1-like cells [73]. Vitamin D has
also been shown to be able to induce Foxp3þ Treg
cells though it remains unclear if the changes in
cytokines contribute to these events [52,53]. The
dynamics between vitamin D and FoxP3þ Treg cells
was confirmed in the study reporting that Treg
induction in peripheral lymphocytes was abolished
in VDR knockout mice in which the utilization of this
nutrient is limited [74].
N-3 Fatty Acids May Modulate Both Antigen-Specific Th1/
Th17 Differentiation and iTreg Function
N-3 fatty acids are commonly known to produce
anti-inflammatory metabolites and thereby reduce
cancer risks [75,76]. Recently, modulating effects of
these fish oil components on immune cell development including T cell differentiation have been
extensively investigated as a part of the mechanism(s)
explaining the observed efficacy of n-3 fatty acids
on the inflammatory processes [54,55,77]. While
these findings appear positive, the study results are
mixed for which the reason remains unclear. For
example, in Fat-1 transgenic mice where n-6 fatty
acids are genetically converted to n-3 fatty
acids [78], n-3 fatty acids are shown to suppress
differentiation of pro-inflammatory Th1/Th17 cells
without altering the expression of Treg cells [55].
On the other hand, in Smad3-/- inflammatory colon
cancer mice, feeding these animals with diet
containing various concentrations (0.75–6%) of
n-3 fatty acids suppressed CD4þ CD8 þ T effector
cell population and increased Treg cell activity [79].
These results suggest that one of the main functions
of n-3 fatty acids may be the maintenance of
homeostasis between effector T cells and Treg cells
that inhibit CD4 þ CD8þ T cell function and
thereby prevent autoimmunity.
Molecular Carcinogenesis
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Modulating Effects of Dietary Polyphenolics on the
Suppressive Activity of iTreg Cells
TGFb, one of the anti-inflammatory cytokines, is
actively induced by myeloid immature DCs within
the tumor microenvironment [80]. When TGFb works
with proinflammatory cytokine IL6, it primes the
differentiation of naı̈ve CD4þ T cells into IL17producing Th17 cells (81, Figure 2). Interestingly,
TGFb is also key to the conversion of peripheral naı̈ve
CD4 þ T cells into Foxp3þ iTregs with regulatory
capacity [82]. This fate decision between Th17 and
Treg cells during differentiation seems to be determined by a ligand activated transcription factor aryl
hydrocarbon receptor (AhR) [83–88] and hypoxiainducible factor-1a (HIF-1a) [89,90]. Recently, it was
shown that AhR-mediated stability and suppressive
activity of iTreg cells require both the expression of a
lineage-determining transcription factor Foxp3 and
epigenetic reprogramming through T cell receptor
(TCR) stimulation [91]. On the other hand, HIF-1a
was reported to mitigate Foxp3 expression by increasing its degradation in the proteasome and thereby
fostering Th17 lineage commitment [89,90]. Nevertheless, the relevance of HIF-1a to the T cell
differentiation has not been fully elucidated yet.
The AhR-related Treg induction and epigenetic
regulation may be modulated by various dietary
polyphenolics including naringenin found in citrus
fruits and epigallocatechin-3-gallate (EGCG) in green
tea [56,57]. These polyphenolics are known to possess
the ability to inhibit the expression of proinflammatory cytokine IL6 [92,93]. Naringenin is a natural
ligand for AhR and the complex stimulates T cell
differentiation toward suppressive Treg cells (56,
Figure 2). While this event seems to occur independently from TGFb, the availability of unoccupied AhR
is considered critical for such effects [56]. Another
dietary polyphenol compound found in tea, EGCG,
was shown to significantly increase Treg frequencies
(1.8 fold) in Balb/c mice when injected (i.p., 50 mg/
kg) for 7 d [57]. This effect of EGCG may involve its
ability to inhibit DNA methyl transferase (DNMT)
activity and thereby increase the expression of Foxp3.
The similar effects of other dietary inhibitors of
DNMT such as sulforaphane [94] and g- tochopherol [95] may support this possibility. Regardless,
further research on the mechanism elucidating the
modulating effects of these dietary components on
Treg expression and their ability to suppress other
effector cells is warranted.
DISCUSSION
The growth and spread of cancer depend not only
on the biological characteristics of the tumor per se
but also on the host responses. Adaptive immune cells
such as B and T cells respond to a specific antigen
while innate lymphocytes including NK cells recognize target cells based on the absence of specific cell
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surface determinants and affect their functions by
simple kill/do not kill decisions. Although innate
immune cells are less sophisticated than adaptive
immune cells in terms of the effector function, these
cells nevertheless are early responders and a front-line
defense against invading pathogens or malignant
non-self molecules. While this tumoricidal activity of
NK cells is critical to protect hosts from invading
pathogens, these cells could also cause autoimmunity
that has been reported to be regulated by Treg cells.
No doubt, it is extremely important to understand the
early stage(s) of pathogen-host interactions, and
redirect these events from a pro-tumor to an antitumor state. Diet may represent a subtle approach to
regulating NK cells without losing their homeostasis
maintained by Treg cells.
The evidence for the antagonizing effect of Treg
cells on NK cell function was first reviewed by Zimmer
et al. in 2008 [96]. Treg cells are produced in the
thymus (nTreg) and are also induced from conventional CD4(þ) T cells at peripheral sites (iTreg). It has
been reported that dietary constituents could modulate iTreg cell function through which they enhance
immune responses without causing autoimmunity.
However, the mechanism explaining the controlling
role of diet-induced Treg cells in NK cell tumoricital
activity remains unclear. Furthermore, considering
the main focus of this paper is on cancer prevention
which usually deals with normal cells and/or premalignant stage of normal cells, studies involving
cancer animal models that could be used to examine
or detect the modulating effects of dietary components on these immune cells have not been covered in
this paper.
Available data suggest that certain sites such as in
the gastrointestinal tract that is continuously exposed

to foods and other exogenous stimuli are dominated
by induced Treg cells that arise from peripheral
conversion, rather than T cell differentiation in the
thymus [6]. These iTreg cells appear to be the main
target for immune-modulating dietary components
such as vitamins A [67], vitamin D [72], n-3 fatty
acids [55], and plant polyphenolics [56], which
contribute to the fine tuning of immune cells to
maintain homeostasis. While these studies suggest
the role of diet-derived nutrients in modulating
gastrointestinal immunity, several questions including if the effects of dietary components are achievable
within the range of physiological concentrations
remain unanswered. To clarify this gap existing in
research area of nutrition and immunity, the dietary
levels along with experimental models adopted in the
reported studies are listed with physiological concentrations of the effective bioactive food components in
human plasma in Table 1. Interestingly, the effects of
RAs and vitamin D on iTreg cells were examined with
the physiologically achievable concentrations in
humans. In contrast, the influence of other dietary
components such as n-3 fatty acids, naringenin, and
EGCG was evaluated with exaggerated concentrations either in vitro or in vivo. Thus, it is suggested
to evaluate the study results with caution because it
remains unclear how the data generated with
high doses in experimental models translate into
humans.
In conclusion, immunoprevention of cancer may
occur by promoting antitumor effector cells such as
NK cells for tumor suppression as well as by counteracting the accompanied autoimmunity through the
enhancement of the immunoregulatory mechanisms
such as Treg activity that inhibits effector cell
cytotoxic properties. When the balance between

Table 1. Dietary Modulation of Treg Cell Induction With a Focus on the Concentrations Adopted for Studies and Their
Human Plasma Levels
BFCsa
Retinoic
acids
Vitamin D

Effects

TGF-b-dependent iTreg
generation at the intestine
Inhibits the maturation of
myeloid DCsb and thereby
increases iTreg
N-3 fatty
Modulate Th1/Th17
acids
differentiation and iTreg
function
Naringenin Stimulates AhR-mediated
Treg induction
EGCGe
Inhibits DNMT and thereby
increases Foxp4 expression
a

Concentration
used in studies

Model

Human
plasma levels

Reference

10–100 nM

C57BL/6 mice

4–14 nM

49, 50, 97

30 mM
[25(OH)D3]

51–53, 98

15–20 mM
C57BL/6 Rag-/- mice
[1, 25 (OH) 2D3]
4–6% of diet

Rag-/- mice

DHAc 3.5 mol/%
EPAd 1.1 mol/%

54, 55,
99, 100

50 mM

Murine splenic
CD4þ T cells
Balb/C mice

1.0 mM

56, 101

0.3 mM

57, 102

7.8 mM

Bioactive food components (BFCs).
Dendritic cells (DCs).
c
Docosahexaenoic acid (DHA, 22:6n-3): The value is presented as mol/% of phospholipid.
d
Eicosapentaenoic acid (EPA, 20:5n-3): The value is presented as mol/% of phospholipid.
e
Epigallocatechin 3-gallate (EGCG).
b
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Figure 3. Nutrients are metabolized to small molecular weight compounds which increase tumoricidal activity of
NK cells and induce the controlling properties of iTreg cells. The modulating effects of nutrients on the expression
and function of iTreg cells are critical to prevent autoimmunity and allergy. When the gut epithelium is transformed
by external stimuli including reactive oxygen species (ROS), pathogens, and inﬂammatory molecules, iTreg cells lose
their stability and function. However, the role of these iTreg cells in tumor microenvironment remains unclear.

immunity and autoimmunity is not maintained
appropriately as in tumors, the Treg cells alter their
polarity and stability to adjust to a new microenvironment. Through these changes, Treg cells are
adopted by malignant cells as a mediator to escape
from immunity and increase their survival [103,104].
While some studies support the general concept that
specific dietary components contribute to immunoprevention by enhancing tumoricidal activity of NK
cells and inducing the controlling properties of Treg
cells (Figure 3), the evidence largely remains indirect.
Therefore, the underlying mechanisms explaining
the precise role of dietary components in maintaining
the balance between immune surveillance and
immune tolerance remain as an emerging research
agenda which warrants further investigation.
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